Aston; Nicola Mary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aston; Nicola Mary.The latest application filed is for "nicotinamide derivates useful as p38 inhibitors".

Company Profile

0.15.17

Aston; Nicola Mary - Stevenage N/A GB
Aston; Nicola Mary - Hertfordshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nicotinamide derivates useful as P38 inhibitors Grant 8,575,204 - Aston , et al. November 5, 2	2013-11-05
Nicotinamide derivatives useful as P38 inhibitors Grant 8,252,818 - Aston , et al. August 28, 2	2012-08-28
Nicotinamide Derivates Useful As P38 Inhibitors App 20100215652 - ASTON; Nicola Mary ; et al.	2010-08-26
Nicotinamide Derivates Useful As P38 Inhibitors App 20100215661 - ASTON; Nicola Mary ; et al.	2010-08-26
Nicotinamide derivatives useful as p38 inhibitors Grant 7,709,506 - Aston , et al. May 4, 2	2010-05-04
Pyrazolo[3,4-b]pyridine Compounds, And Their Use As Pde4 Inhibitors App 20090325952 - Allen; David George ; et al.	2009-12-31
Pyrazolo[3,4-b]pyridine Compounds, And Their Use As Pde4 Inhibitors App 20090318494 - Allen; David George ; et al.	2009-12-24
Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors Grant 7,626,055 - Aston December 1, 2	2009-12-01
Biphenyl carboxylic amide p38 kinase inhibitors Grant 7,572,790 - Aston , et al. August 11, 2	2009-08-11
Nicotinamide derivatives useful as p38 inhibitors Grant 7,514,456 - Aston , et al. April 7, 2	2009-04-07
Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4) App 20080280911 - Aston; Nicola Mary ; et al.	2008-11-13
5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors Grant 7,432,289 - Angell , et al. October 7, 2	2008-10-07
5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors Grant 7,396,843 - Angell , et al. July 8, 2	2008-07-08
Biphenylcarboxylic amide derivatives as p38 kinase inhibitors Grant 7,309,800 - Angell , et al. December 18, 2	2007-12-18
Biphenylcarboxylic amide derivatives as p38 kinase inhibitors Grant 7,271,289 - Aston September 18, 2	2007-09-18
Biphenyl-Derivatives as p38 Kinase Inhibitors App 20070142476 - Angell; Richard Martyn ; et al.	2007-06-21
Biphenyl carboxylic amide p38 kinase inhibitors App 20070129354 - Aston; Nicola Mary ; et al.	2007-06-07
Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors App 20070105860 - Angell; Richard Martyn ; et al.	2007-05-10
Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors App 20070105850 - Aston; Nicola Mary	2007-05-10
5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors Grant 7,208,629 - Angell , et al. April 24, 2	2007-04-24
Biphenyl-derivatives as p38-kinase inhibitors Grant 7,183,297 - Angell , et al. February 27, 2	2007-02-27
Biphenylcarboxylic amide derivatives as p38-kinase inhibitors Grant 7,151,118 - Angell , et al. December 19, 2	2006-12-19
Nicotinamide Derivatives Useful as p38 Inhibitors App 20060276516 - Aston; Nicola Mary ; et al.	2006-12-07
Biphenylcarboxylic amide derivatives as p38 kinase inhibitors App 20060241179 - Aston; Nicola Mary	2006-10-26
Nicotinamide derivatives useful as p38 inhibitors. Grant 7,125,898 - Aston , et al. October 24, 2	2006-10-24
Nicotinamide derivatives useful as p38 inhibitors App 20050176964 - Aston, Nicola Mary ; et al.	2005-08-11
5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors App 20050038014 - Angell, Richard Martyn ; et al.	2005-02-17
Biphenylcarboxylic amide derivatives as p38-kinase inhibitors App 20050020540 - Angell, Richard Martyn ; et al.	2005-01-27
5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors App 20040267012 - Angell, Richard Martyn ; et al.	2004-12-30
Biphenyl-derivatives as p38-kinase inhibitors App 20040249161 - Angell, Richard Martyn ; et al.	2004-12-09
5-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors App 20040242868 - Angell, Richard Martyn ; et al.	2004-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.